Follow the Nectar Lifesciences Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Nectar Lifesciences Limited has logged 11 public disclosures. Market capitalisation: €5.2bn. The latest transaction was reported on 27 November 2025 (Sale). Among the most active insiders: Sanjiv Goyal. Every trade is accessible without an account.
11
Insider Decl.
0
Thresholds
€201,813
2 ops.
Buy Volume
·
1 ops.
Sell Volume
21Σ signal
Buys €201,813· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 26,072 of 26,282 companies
6.5
score / 100
Value
1
Quality
13
FCF yld-167%
Earn yld-135%
EV/EBITDA·
ROE-7.5%
Gross mgn8.3%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.